Literature DB >> 3263501

Fibromyalgia: generalized pain intolerance and manifold symptom reporting.

L G Quimby1, S R Block, G M Gratwick.   

Abstract

We tested the current criteria for fibromyalgia. Pain tolerance was measured at tender point and control point sites using a pressure algometer, and responses to 6 standard psychological self-reports were obtained from 125 patients with generalized nonarticular rheumatism, rheumatoid arthritis, or osteoarthritis. Among patients with generalized nonarticular rheumatism, published symptom criteria for fibromyalgia did not correlate significantly with the number of tender points. Only lower generalized pressure point pain tolerance distinguished fibromyalgia from other generalized nonarticular rheumatism. Generalized nonarticular rheumatism mean scores were much higher than controls on tests measuring the tendency to report physical symptoms, including headaches and functional bowel syndrome. It is probable that patients with fibromyalgia do not differ in any important physical or psychological respect from other patients with generalized nonarticular rheumatism except for the presence of tender points. However, the presence of tender points is merely a reflection of the patient's general pressure pain sensitivity and is not indicative of any special localized pathological phenomenon. The concept of fibromyalgia as an entity separate from the rest of generalized nonarticular rheumatism may be an artifact of a physician's approach to the patient. Most patients with generalized nonarticular rheumatism demonstrate an abnormally high frequency of reporting manifold disagreeable symptoms and probably come to the attention of many medical disciplines.

Entities:  

Mesh:

Year:  1988        PMID: 3263501

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes.

Authors:  Roland Staud; Elizabeth E Weyl; Donald D Price; Michael E Robinson
Journal:  J Pain       Date:  2012-06-26       Impact factor: 5.820

2.  Different concepts of chronic musculoskeletal pain.

Authors:  M Awerbuch
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

3.  Depressed fibromyalgia patients are equipped with an emphatic competence dependent self-esteem.

Authors:  M Johnson; M L Paananen; P Rahinantti; P Hannonen
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

4.  Nature of passive musculoarticular stiffness increase of ankle in female subjects with fibromyalgia syndrome.

Authors:  Frédéric Dierick; Christine Detrembleur; Guilhem Trintignac; Etienne Masquelier
Journal:  Eur J Appl Physiol       Date:  2011-02-06       Impact factor: 3.078

Review 5.  Peripheral pain mechanisms in chronic widespread pain.

Authors:  Roland Staud
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

Review 6.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

Review 7.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Pain Headache Rep       Date:  2005-10

Review 8.  Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Arthritis Res Ther       Date:  2006-04-24       Impact factor: 5.156

9.  General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study.

Authors:  Karin Björkegren; Mari-Ann Wallander; Saga Johansson; Kurt Svärdsudd
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

10.  Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult.

Authors:  D V Tillu; G F Gebhart; K A Sluka
Journal:  Pain       Date:  2007-08-30       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.